KALDVIK AS (KLDVK): Further update on jellyfish event in Reyðarfjörður

Kaldvík estimates the jellyfish event caused approximately 11.5 percentage points of additional mortality in the affected 2025 generation since 4 September, up from 6.5 percentage points reported on 15 September. Jellyfish presence has subsided and biological conditions have normalized; 2026 harvest guidance remains unchanged at approximately 17,000 tonnes. Further biological performance details are due with the Q3 presentation on 13 November 2026.

Analysis

The key risk is not simply lost fish: additional mortality at the affected sites may reduce saleable biomass and worsen unit costs even if the 2026 tonnage target is met, depending on harvest weights, replacement growth and site-level economics. Unchanged guidance therefore limits near-term volume concern but does not establish that earnings or cash flow are intact. The prior lender waiver makes the financial transmission important: weaker realized biomass or higher costs could matter more if covenant headroom is narrow. The announcement provides no quantified earnings impact, liquidity runway or waiver conditions; those are the variables to verify rather than assume.

Near term, the subsided jellyfish presence and normalized site conditions reduce the chance of further acute biological deterioration. The next meaningful catalyst is the 13 November Q3 update, particularly survival by generation and site, biomass, harvest-weight assumptions, cost per kg, cash-flow impact and financing headroom. Over 6–18 months, any need to rebuild affected cohorts could constrain production flexibility, but the announcement does not establish that outcome.

Contrarian read: the unchanged harvest outlook and normalization may limit downside if investors focus on mortality alone. Conversely, harvest guidance is a volume measure, not proof of preserved margins. Without the financial bridge and lender terms, the signal is negative but insufficient for a high-conviction directional trade.

Key Decisions for Investors

• Avoid adding to KLDVK ahead of the Q3 disclosure; for existing exposure, size risk around the unresolved earnings and liquidity impact rather than treating unchanged harvest guidance as an all-clear.
• Make the 13 November presentation the decision point. Require site- and generation-level survival, expected harvest weight, unit-cost implications, cash-flow effects and the waiver's covenant/headroom terms before upgrading the thesis.
• Treat a confirmed 2026 harvest shortfall, deterioration in cash-flow guidance, or limited lender headroom as thesis-negative; stable harvest delivery alongside quantified, manageable cost impact and adequate financing headroom would weaken the downside case.
• No sector pair is warranted from this update alone: the company-specific biological exposure is clearer than any evidence of relative mispricing versus other salmon producers.